Bryan Johnson diagnosed with autoimmune gastritis
Analysis based on 34 articles · First reported Jul 01, 2026 · Last updated Jul 08, 2026
The news may draw attention to Johnson's longevity ventures and the broader field of biohacking, potentially influencing investor interest in related biotech and health optimization companies. However, as a personal health disclosure, the direct market impact is limited.
Bryan Johnson, the tech entrepreneur and biohacker known for his anti-aging project Blueprint, revealed in July 2026 that he has been diagnosed with autoimmune gastritis (AIG), an incurable autoimmune disease where the immune system attacks the stomach lining. Johnson, 48, announced the diagnosis on social media, stating 'my stomach is eating itself.' He was officially diagnosed in May 2026 after years of unexplained low ferritin levels and a history of hypothyroidism. Johnson plans to pursue experimental treatments, including immune-modulating therapies and engineered cell therapy, aiming to find a cure despite current medical consensus that AIG is manageable but not curable. The condition affects 2-5% of the population and can lead to nutritional deficiencies, anemia, and increased cancer risk.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard